VistaGen Therapeutics, Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine
Article By: ChinaBio® Today
Saturday, August 8, 2020 12:13 PM EDT
BioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture, and market AstraZeneca's COVID-19 vaccine in China. Biogen announced a $2 billion deal to partner Denali Therapeutics' potential Parkinson's Disease therapy.
In this article: AZN, BIIB, VTGN, GTHX, ZLAB, DNLI, DCPH
Premarket Biotech Digest – DMPI Receives Approval, PFE Slapped From FDA
Article By: KKD Healthcare Analytics
Friday, June 23, 2017 9:31 AM EDT
DelMar Pharmaceuticals announced that it has received Institutional Review Board approval to conduct a Phase 3 clinical trial. Pfizer received a setback from the FDA. Roche announced receiving the FDA approval .

Latest Tweets for $VTGN

No tweets yet!


Rotation Opportunity As Three Top Psychedelic Stocks Explode
Corey Gaber 12/15/2020 3:37:26 AM

Great article TalkMarkets $MMEDF has been a BANGER $VTGN

is Kim Jong gonna make everyone take PH10??!!!!

VistaGen Therapeutics: Interesting Prospects
Alexis Renault 10/5/2017 7:43:59 PM

Thanks Terry! Will take a closer look at $VTGN.

VistaGen Therapeutics: Interesting Prospects
Derek Snyder 10/4/2017 9:07:54 AM

Your argument for acquisition sounds convincing, but I wonder if there have been any such overtures. Know if that's the case? Which companies would be the most likely to target #Vistagen? $VTGN.

VistaGen Therapeutics: Interesting Prospects
David M. Green 10/4/2017 2:43:18 AM

Looks promising. Sounds like $VTGN should be getting more love from investors.

VistaGen Therapeutics: Interesting Prospects
Bill Johnson 10/3/2017 10:34:18 PM

Definitely sounds like some interesting prospects indeed! $VTGN

1 to 5 of 5 comments